Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
The present invention relates to pyrrolo[3,2-c]pyridine-4-one 2-indolinone compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein R, R, R, R, R, R, R, RX, Y andhave the meaning cited in the specification. Also disclosed are the pharmaceutical compositions containing the foregoing compounds, methods for the preparation and pharmaceutical use thereof, particularly as protein kinase inhibitors. Formula (I).
UAA200809752A2006-01-272007-01-24Pyrrolo[3,2-c]pyridine-4-one 2-indolinone protein kinase inhibitors
UA92776C2
(en)